Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07753811Completed
Open-label trial of isotretinoin in acne vulgaris (2 arms), sponsored by Benha University. Primary endpoints: Meibomian Gland Morphology at 6 months and Ocular Surface Disease Index at 6 months. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07753811.